A Phase Ib Dose De-escalation Study With BYL719 in Premenopausal Patients With Locally Advanced or Metastatic Breast Cancer
Clinical trial NCT02058381 · COMPLETED
Trial details
- NCT number
- NCT02058381
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2014-05-06
- Primary completion
- 2018-06-19
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.